Shanghai Junshi Biosciences Co., Ltd.
HKSE: 1877.HK0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Hong Kong Stock Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Cong Li
- Employees
- 2,578
- Headquarters
- Shanghai, China
- IPO year
- 2018
- Market cap
- HK$34.5B
- Website
- https://www.junshipharma.com
Loading 1877…
Loading profile data…Frequently asked questions about 1877
What does Shanghai Junshi Biosciences Co., Ltd. (1877.HK) do?
Shanghai Junshi Biosciences Co., Ltd., a biopharmaceutical company, engages in the discovery, development, and commercialization of various drugs in the therapeutic areas of oncology, metabolic, autoimmune, neurologic, and infectious diseases in the People's Republic of China. The company offers JS001, a recombinant humanized anti-PD-1 monoclona...
Where does 1877.HK trade?
Shanghai Junshi Biosciences Co., Ltd. (1877.HK) trades on the Hong Kong Stock Exchange.
What sector is 1877.HK in?
Shanghai Junshi Biosciences Co., Ltd. (1877.HK) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Shanghai Junshi Biosciences Co., Ltd.?
Cong Li is the chief executive officer of Shanghai Junshi Biosciences Co., Ltd. (1877.HK).
Where is Shanghai Junshi Biosciences Co., Ltd. headquartered?
Shanghai Junshi Biosciences Co., Ltd. is headquartered in China.
Does 1877.HK pay a dividend?
Shanghai Junshi Biosciences Co., Ltd. (1877.HK) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did 1877.HK go public?
Shanghai Junshi Biosciences Co., Ltd. (1877.HK) completed its initial public offering in 2018.